<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reactive oxygen species (ROS) and compromised <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense may contribute to <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain disorders</z:e> such as <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0007354'>amyotrophic lateral sclerosis</z:hpo>, etc </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="29767">Nitroxides</z:chebi> are redox-sensitive paramagnetic contrast agents and <z:chebi fb="11" ids="22586">antioxidants</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The ability of a blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>)-permeable <z:chebi fb="0" ids="29767">nitroxide</z:chebi>, <z:chebi fb="0" ids="52088">methoxycarbonyl</z:chebi>-2,2,5,5-tetramethylpyrrolidine-1-oxyl (MC-P), as a magnetic resonance-imaging (MRI) contrast agent for brain tissue redox imaging was tested </plain></SENT>
<SENT sid="3" pm="."><plain>MC-P relaxation in rodent brain was quantified by MRI using a fast Look-Locker T(1)-mapping sequence </plain></SENT>
<SENT sid="4" pm="."><plain>In the cerebral cortex and thalamus, the MRI signal intensity increased up to 50% after MC-P injection, but increased only by 2.7% when a <z:chebi fb="2" ids="33602">BBB</z:chebi>-impermeable <z:chebi fb="0" ids="29767">nitroxide</z:chebi>, 3CxP (3-carboxy-2,2,5,5,5-tetramethylpyrrolidine-1-oxyl) was used </plain></SENT>
<SENT sid="5" pm="."><plain>The maximum concentrations in the thalamus and cerebral cortex after MC-P injection were calculated to be 1.9+/-0.35 and 3.0+/-0.50 mmol/L, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>These values were consistent with the ex vivo data of brain tissue and blood concentration obtained by electron paramagnetic resonance (EPR) spectroscopy </plain></SENT>
<SENT sid="7" pm="."><plain>Also, reduction rates of MC-P were significantly decreased after reperfusion following transient MCAO (middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>), a condition associated with changes in redox status resulting from oxidative damage </plain></SENT>
<SENT sid="8" pm="."><plain>These results show the use of <z:chebi fb="2" ids="33602">BBB</z:chebi>-permeable <z:chebi fb="0" ids="29767">nitroxides</z:chebi> as MRI contrast agents and <z:chebi fb="11" ids="22586">antioxidants</z:chebi> to evaluate the role of ROS in <z:e sem="disease" ids="C1456669" disease_type="Disease or Syndrome" abbrv="">neurologic diseases</z:e> </plain></SENT>
</text></document>